A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design

By afschroeder • March 31, 2026

Wazni OM, Chun KJ, Amin A, Anic A, Ajijola OA, Gibson DN, Mansour M, Makati K, Chrispin J, Duytschaever M, Nair DG, Piccini JP, Natale A, Raciti G, Wehrenberg S, McCammon S, Albrecht EM, Garlitski A, Sutton BS, Andrade JG; AVANT GUARD Investigators. A randomized controlled trial of pulsed field ablation vs antiarrhythmic therapy as a first-line treatment for persistent atrial fibrillation: The AVANT GUARD trial rationale and design. Heart Rhythm O2. 2025 Dec 23;7(3):561-574. doi: 10.1016/j.hroo.2025.12.011. PMID: 41908201; PMCID: PMC13031045.

Tags: antiarrhythmic drugs, Cardiology/Epi, catheter ablation, First-line therapy, persistent atrial fibrillation, Publications, pulsed field ablation, Randomized Controlled Trial

Association of care fragmentation with financial and clinical outcomes of transcatheter aortic valve replacement in the US: A retrospective cohort study

Chaturvedi A, Mallick S, Le NK, Tabibian K, Balian J, Yalzadeh D, Badiee B, Zinoviev R, Benharash P. Association of care fragmentation with financial and[...]

Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling

Liu S, Gammon ST, Tan L, Gao Y, Kim K, Elbatreek MH, Arrieta A, Williamson IK, Salazar RL, Pham J, Davidian A, Khanna Neicheril R,[...]

Dashboard-Directed Intervention to Improve Guideline-Directed Heart Failure Therapy for Veterans

Sheng Q, Brownell NK, Hsu JJ, Chang DS, Fonarow GC, Ziaeian B. Dashboard-Directed Intervention to Improve Guideline-Directed Heart Failure Therapy for Veterans. JACC Adv. 2026[...]